Contribution of the BRAF oncogene in the preoperative phase of thyroid carcinoma

Author：

ISSN： 1792-1074

Source： Oncology Letters, Vol.6, Iss.1, 2013-01, pp. : 191-196

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Is BRAF mutation screening useful for preoperative risk stratification in papillary thyroid cancer?

By Soares Paula Sobrinho-Simõões Manuel

Future Oncology, Vol. 5, Iss. 8, 2009-10 ,pp. : 1225-1229

Future Medicine

Access to resources Recommend Favorite

Utility of BRAF protein overexpression in predicting the metastasis potential of papillary thyroid carcinoma

Oncology Letters, Vol. 2, Iss. 1, 2011-01 ,pp. : 59-63

Spandidos Publications

Access to resources Recommend Favorite

Prognostic value of the BRAF V600E mutation in papillary thyroid carcinoma

By He Guoping Zhao Baojian Zhang Xu Gong Rixiang

Oncology Letters, Vol. 7, Iss. 2, 2014-02 ,pp. : 439-443

Spandidos Publications

Access to resources Recommend Favorite

BRAF mutations in papillary thyroid carcinoma and emerging targeted therapies (Review)

Molecular Medicine Reports, Vol. 6, Iss. 4, 2012-01 ,pp. : 687-694

Spandidos Publications

Access to resources Recommend Favorite

BRAF mutation is not predictive of long‐term outcome in papillary thyroid carcinoma

Cancer Medicine, Vol. 4, Iss. 6, 2015-06 ,pp. : 791-799

John Wiley & Sons Inc

Access to resources Recommend Favorite